Boston Scientific Corporation (NYSE: BSX) announces positive clinical data from the Research in Severe Asthma (RISA) Trial, demonstrating the long-term safety of bronchial thermoplasty (BT) in patients treated with the Company’s AlairTM Bronchial Thermoplasty System. Follow-up data demonstrate that stable lung function is maintained and late clinical complications are absent over a five-year period in patients with severe refractory asthma treated with BT. Results were presented today at the annual European Respiratory Society (ERS) Congress in Amsterdam by Michel Laviolette, M.D., Professor of Medicine, Institut universitaire de cardiologie et de pneumologie at Université Laval in Québec City, Canada.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/bostonscientific/52128/
Go to http://www.manageyourtreatment.org for more information.
Cancer has touched the lives of all of us. Each year, it takes the lives of more than half a million Americans and seven million people worldwide.
Cynthia Nixon and Edie Falco will appear in this PSA to encourage cancer patients to win back some control in their lives by managing their treatment. In their role as the campaign ambassadors, Falco and Nixon appear to encourage people to better understand their options and provide support for managing their care.
After a successful pilot program in October 2009, Cancer Treatment Centers of America (CTCA) is introducing an innovative approach to cancer treatment this July at each of its four hospitals in suburban Chicago, Philadelphia, Tulsa and suburban Phoenix. Called “Patient Empowered CareSM,” this advancement in the patient treatment delivery process offers patients an average of between two and three hours with a dedicated team of specialized oncology physicians and clinicians.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cancercenter/44523/
CareFusion (NYSE: CFN), a leading global medical technology company, today announced the launch of the ReVel™ ventilator, a new high performance, portable device designed for pediatric to adult (min. 5Kg) patients who require breathing support during transport.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/carefusion/50615/
Boston Scientific Corporation (NYSE: BSX) introduces its CardioTeach™ iPad® app, an industry-first, free educational resource to help healthcare professionals better educate patients and caregivers about therapy options related to cardiovascular and peripheral diseases, specifically atrial and ventricular arrhythmias, coronary artery disease, heart failure, heart rhythm disorders and peripheral vascular disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/43509-boston-scientific-cardioteach-ipad-app
The Bonnie J. Addario Lung Cancer Foundation invites you to join The Living Room, a lively and interactive online support group for those who are directly and indirectly affected by lung cancer. The April Living Room will feature a patient-focused program, titled “Sharing My Personal Journey.” There’s no guest speaker this month, just stories and experiences from patients and family who can offer hope to others.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56176-bjalcf-the-living-room-online-support-group-sharing-my-personal-journey
According to a recent national survey, 17.1 percent of Americans lack health insurance, and more than nine million of the nation’s uninsured rely on federally qualified health centers (FQHC), non-profit community clinics and free clinics each year for primary care. While these clinics serve the critical health care needs of the uninsured, patients oftentimes cannot afford the medications prescribed by the clinic’s physicians, or navigate a fragmented system that only offers partial solutions. This is a particularly growing problem for America’s working poor.
Today, Medco Foundation and Dispensary of Hope (DOH), a not-for-profit pharmacy-focused social venture for the uninsured, introduced a new, national initiative to substantially improve the supply, delivery and management of critical prescription drugs to thousands of uninsured Americans who are managing a chronic illness.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54424-medco-dispensary-of-hope-prescription-drug-program-clinics-uninsured
Current drug shortages in the U.S., while disruptive and of increasing concern to patients, clinicians and policymakers, are limited primarily to generic injectables and a few key disease areas, according to an IMS Institute for Healthcare Informatics study released today. The new study, Drug Shortages: A Closer Look at Products, Suppliers and Volume Volatility, offers a comprehensive examination of drug shortages and recommends that healthcare stakeholders work toward the creation of an early warning system to minimize future patient care disruptions.
To multimedia News Release, go to http://www.multivu.com/mnr/53215-ims-institute-for-healthcare-informatics-drug-shortage-study
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company’s novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection (CDI). The Phase 3 trial showed that fidaxomicin significantly reduced recurrence rates and increased global cure rates when compared to vancomycin, the only treatment approved by the U.S. Food and Drug Administration for CDI. The article titled,
Sermo, Inc. (www.sermo.com), the largest online network in the United States exclusive to physicians, today introduced Sermo Mobile, an application that allows physicians to access the country’s greatest concentration of medical knowledge in real-time. Sermo Mobile builds on Sermo’s current web platform, an online resource where physicians from across 68 specialties and all 50 states collaborate, discuss and consult with each other to provide the highest quality care to their patients.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51104-sermo-launches-real-time-medicine-mobile-app-for-physicians
Urgent coordinated action from national governments, medical societies and patient organizations is needed to avoid a public health crisis resulting from the tide of preventable strokes that leave many people with atrial fibrillation (AF) mentally and physically disabled or dead, every year. How Can We Avoid a Stroke Crisis in Latin America?, a report from Action for Stroke Prevention – a group of health experts from around the world - reveals the huge economic, social and personal burden of AF-related strokes across the region. Launched today at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 3rd Latin America Conference, the report proposes measures to tackle stroke in patients with AF, the most common, sustained abnormal heart rhythm and a major cause of stroke.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/strikeoutstroke/50549/
University Hospitals (UH) Case Medical Center has announced a $250 million initiative that promises to dramatically change how drugs will advance from discovery in the laboratories to commercialization, resulting in greater access to advanced treatments and cures for patients. The first-of-its-kind initiative, named The Harrington Project for Discovery & Development, is powered by a $50 million gift – the largest donation in the health system’s history – from the Harrington family, recognized entrepreneurs and philanthropists in Cleveland.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54909-university-hospitals-uh-harrington-discovery-institute-development-project
